ru24.pro
News in English
Август
2024

Новости за 01.08.2024

Paris Olympics: Japan’s Shinnosuke Oka wins men’s all-around title

Sports.inquirer.net 

PARIS — Shinnosuke Oka won the men’s all-around gymnastics title at the Paris Olympics on Wednesday, upsetting the two main favorites to extend Japan’s dominance in a final that came down to the wire. The former junior world champion whose career was put on hold by a serious knee injury two years ago edged Zhang

Culprits in Gomtinagar harassment case will be punished severely: CM Adityanath

BigNewsNetwork.com (sports) 

Lucknow (Uttar Pradesh) [India], August 1 (ANI): Uttar Pradesh Chief Minister Yogi Adityanath on Thursday said that ensuring women's safety is one of the main priorities of his government and assured that culprits behind the Gomtinagar harassment incident will be punished severely. The chief minister's statement in the Assembly came a day after a video showed revellers harassing a couple on a bike in Gomtinagar, Lucknow.

Indian Army's Lieutenant Colonel Ashok becomes youngest referee in boxing at Paris Olympics

BigNewsNetwork.com (sports) 

New Delhi [India], August 1 (ANI): In a remarkable achievement, Lieutenant Colonel Kabilan Sai Ashok, a serving Indian Army officer, has become the youngest Olympic referee in boxing from India at the Paris Olympics 2024. This milestone reflects his exceptional dedication, professionalism, and integrity, embodying the high standards of the Indian Army. Currently serving in the Indian Army as Joint Secretary at the Service

Sanofi gets drug regulator nod to market RSV therapy in India

Economictimes.indiatimes.com 

French drugmaker Sanofi announced on Thursday that it has received approval from India's Central Drugs Standard Control Organization (CDSCO) to market its novel therapy, Beyfortus, in India. The therapy is aimed at protecting newborns and infants from respiratory syncytial virus (RSV).

Lilly says weight loss drug cuts heart failure risk by 38% in trial - Reuters

Top Stories (us) - Google News (ru) 

  1. Lilly says weight loss drug cuts heart failure risk by 38% in trial  Reuters
  2. Lilly's tirzepatide successful in phase 3 study showing benefit in adults with heart failure with preserved ejection fraction and obesity  Investors | Eli Lilly and Company
  3. Live news: Tech sell-off drags Nasdaq and S&P 500 lower  Financial Times
  4. Eli Lilly says tirzepatide showed positive results in late-stage trial evaluating it as treatment for heart failure  MarketWatch